Telemedicine

The DEA conducted a two day listening session last week to receive practitioner comments on  regulations relating to the prescribing of controlled substances via telemedicine.   Transcripts of the public comments are available for viewing at this link:  https://www.deadiversion.usdoj.gov/Telemedicine_listening_session.html. According to reporting by Fierce HealthCare, the listening sessions were held in response to a backlash from…